Infliximab‐induced autoimmune hepatitis requiring liver transplantation

Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab‐i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Frederick, Al Ibrahim, Bashaar, Walsh, Joanna, Qumosani, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878066/
https://www.ncbi.nlm.nih.gov/pubmed/31788265
http://dx.doi.org/10.1002/ccr3.2456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878066/
https://www.ncbi.nlm.nih.gov/pubmed/31788265
http://dx.doi.org/10.1002/ccr3.2456

Ejemplares similares